| Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum. P Onali, MC Olianas, GL Gessa Molecular pharmacology 28 (2), 138-145, 1985 | 342 | 1985 |
| Selective blockade of dopamine D-1 receptors by SCH 23390 discloses striatal dopamine D-2 receptors mediating the inhibition of adenylate cyclase in rats. P Onali, MC Olianas, GL Gessa European Journal of Pharmacology 99 (1), 127-128, 1984 | 233 | 1984 |
| Adenylate cyclase activity of synaptic membranes from rat striatum. Inhibition by muscarinic receptor agonists. MC Olianas, P Onali, NH Neff, E Costa Molecular Pharmacology 23 (2), 393-398, 1983 | 183 | 1983 |
| The striatal dopaminergic function is mediated by the inhibition of a nigral, non-dopaminergic neuronal system via a strio-nigral GABAergic pathway MC Olianas, GM De Montis, G Mulas, A Tagliamonte European journal of pharmacology 49 (3), 233-241, 1978 | 164 | 1978 |
| Role of GABA in the striatal output system: globus pallidus, nucleus entopeduncularis, substantia nigra and nucleus subthalamicus J Scheel-Krüger, G Magelund, MC Olianas Advances in biochemical psychopharmacology 30, 165-186, 1981 | 132 | 1981 |
| Intranigral kainic acid is evidence that nigral non-dopaminergic neurones control posture G DI CHIARA, M OLIANAS, M Del Fiacco, PF Spano, A Tagliamonte Nature 268 (5622), 743-745, 1977 | 131 | 1977 |
| Selective increase of brain dopamine synthesis by sulpiride A Tagliamonte, G Montis, M Olianas, L Vargiu, GU Corsini, GL Gessa Journal of Neurochemistry 24 (4), 707-710, 1975 | 121 | 1975 |
| Intranigral kainic acid: evidence for nigral non-dopaminergic neurons controlling posture and behavior in a manner opposite to the dopaminergic ones MC Olianas, GM De Montis, A Concu, A Tagliamonte, G Di Chiara European Journal of Pharmacology 49 (3), 223-232, 1978 | 96 | 1978 |
| Rat striatal muscarinic receptors coupled to the inhibition of adenylyl cyclase activity: potent block by the selective m4 ligand muscarinic toxin 3 (MT3) MC Olianas, A Adem, E Karlsson, P Onali British journal of pharmacology 118 (2), 283-288, 1996 | 90 | 1996 |
| Behavioural functions of GABA in basal ganglia and limbic system J Scheel-Krüger, J Arnt, G Magelund, M Olianas, B Przewlocka, ... Brain Research Bulletin 5, 261-267, 1980 | 83 | 1980 |
| Interferon‐β induces apoptosis in human SH‐SY5Y neuroblastoma cells through activation of JAK–STAT signaling and down‐regulation of PI3K/Akt pathway S Dedoni, MC Olianas, P Onali Journal of neurochemistry 115 (6), 1421-1433, 2010 | 81 | 2010 |
| Mixed agonist–antagonist properties of clozapine at different human cloned muscarinic receptor subtypes expressed in Chinese hamster ovary cells MC Olianas, C Maullu, P Onali Neuropsychopharmacology 20 (3), 263-270, 1999 | 81 | 1999 |
| Evidence that adenosine A2 and dopamine autoreceptors antagonistically regulate tyrosine hydroxylase activity in rat striatal synaptosomes P Onali, MC Olianas, B Bunse Brain research 456 (2), 302-309, 1988 | 79 | 1988 |
| In GH3 pituitary cells, acetylcholine and vasoactive intestinal peptide antagonistically modulate adenylate cyclase, cyclic AMP content, and prolactin secretion. P Onali, C Eva, MC Olianas, JP Schwartz, E Costa Molecular pharmacology 24 (2), 189-194, 1983 | 69 | 1983 |
| Evidence that a nigral gabaergic-chrolinergic balance controls posture GM De Montis, MC Olianas, G Serra, A Tagliamonte, J Scheel-Krüger European journal of pharmacology 53 (2), 181-190, 1979 | 69 | 1979 |
| Possible role of insulin in the transport of tyrosine and tryptophan from blood to brain A Tagliamonte, MG DeMontis, M Olianas, PL Onali, GL Gessa Pharmacological Research Communications 7 (6), 493-499, 1975 | 68 | 1975 |
| Inhibition of acetylcholine muscarinic M1 receptor function by the M1‐selective ligand muscarinic toxin 7 (MT‐7) MC Olianas, C Maullu, A Adem, E Mulugeta, E Karlsson, P Onali British journal of pharmacology 131 (3), 447-452, 2000 | 56 | 2000 |
| Effects of clozapine on rat striatal muscarinic receptors coupled to inhibition of adenylyl cyclase activity and on the human cloned m4 receptor MC Olianas, C Maullu, P Onali British journal of pharmacology 122 (3), 401-408, 1997 | 56 | 1997 |
| Increase in large neutral amino acid transport into brain by insulin MG De Montis, MC Olianas, B Haber, A Tagliamonte Journal of Neurochemistry 30 (1), 121-124, 1978 | 56 | 1978 |
| Activation of nociceptin/orphanin FQ‐NOP receptor system inhibits tyrosine hydroxylase phosphorylation, dopamine synthesis, and dopamine D1 receptor … MC Olianas, S Dedoni, M Boi, P Onali Journal of neurochemistry 107 (2), 544-556, 2008 | 55 | 2008 |
